Latest stories on FEMY
Femasys Advances OB/GYN Expansion with Adoption of FemaSeed® Fertility Portfolio by Minnesota Women’s Care
GlobeNewswire63 · neutralproduct/pr
Femasys Advances OB/GYN Expansion with Adoption of FemaSeed® Fertility Portfolio by Minnesota Women’s Care
StockTitan63 · neutralproduct/pr
Femasys partners with CapexMD to expand patient access
The Fly66 · bullishproduct/pr
Femasys Partners with CapexMD to Expand Patient Access to FemaSeed® Fertility Portfolio
GlobeNewswire63 · neutralproduct/pr
Femasys Partners with CapexMD to Expand Patient Access to FemaSeed® Fertility Portfolio
StockTitan63 · neutralproduct/pr
Femasys registers to sell 28.12M shares of common stock for holders
The Fly24 · bearishgeneral
Femasys announces fertility partnership with UNC Health
The Fly56 · neutralproduct/pr
Femasys Partners with UNC Health to Introduce Its FemaSeed® Fertility Portfolio Across Statewide OB/GYN Care Locations
Business Insider63 · neutralproduct/pr
Femasys Partners with UNC Health to Introduce Its FemaSeed® Fertility Portfolio Across Statewide OB/GYN Care Locations
GlobeNewswire63 · neutralproduct/pr
FEMY Stock Rallies On Key Regulatory Milestone For Investigational Birth Control Technology – Retail Sees 500% Upside Potential
Stocktwits News73 · bullishgeneral
Femasys Secures FDA Approval for Modular PMA Pathway for FemBloc
InvestorsHub67 · bullishproduct/pr
FDA Approves Modular PMA Pathway for Femasys’ FemBloc—Clearing a Major Regulatory Hurdle for Non-Surgical Birth Control Innovation
MarketChameleon72 · bullishproduct/pr
Femasys announces FDA approval of FemBloc modular premarket approval application
The Fly73 · bullishproduct/pr
Femasys Announces FDA Approval of Modular PMA Submission Approach for FemBloc®
StockTitan73 · bullishproduct/pr
Femasys price target lowered to $10 from $30 at Lake Street
The Fly28 · bearishanalyst
Femasys GAAP EPS of -$1.33, revenue of $0.33M
Seeking Alpha28 · bearishearnings
Femasys price target lowered to $10 from $30 at Maxim
The Fly34 · bearishanalyst
FEMASYS INC (FEMY) files 8-K
SEC 8-K50 · neutralgeneral
Femasys Announces Financial Results for Quarter Ended June 30, 2026 and Provides Corporate Update
Business Insider50 · neutralgeneral
Femasys Announces Financial Results for Quarter Ended June 30, 2026 and Provides Corporate Update
GlobeNewswire59 · neutralgeneral
Femasys Strengthens and Extends Global Patent Protection for FemBloc® with First Issued Blended Polymer Patents
StockTitan63 · neutralproduct/pr
FEMASYS INC (FEMY) files 8-K
SEC 8-K50 · neutralgeneral
Femasys Announces 30m Private Placement
The Fly28 · bearishgeneral
Femasys Secures $30 Million Private Placement, with Potential Proceeds of Up to $90 Million
Business Insider24 · bearishgeneral